Journal of Acute Care

Register      Login

VOLUME 3 , ISSUE 1 ( January-April, 2024 ) > List of Articles


Healthcare-associated Infection Surveillance in Low- and Middle-income Countries: Challenges, Opportunities, and the Way Forward

Shaeel Ashraf, Divendu Bhushan, Mariyam Zaheer

Keywords : Healthcare-associated infections surveillance, Healthcare-associated infections, International collaboration, Patient safety, Risk factors

Citation Information : Ashraf S, Bhushan D, Zaheer M. Healthcare-associated Infection Surveillance in Low- and Middle-income Countries: Challenges, Opportunities, and the Way Forward. 2024; 3 (1):12-17.

DOI: 10.5005/jp-journals-10089-0078

License: CC BY-NC 4.0

Published Online: 30-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


With a substantial impact on patient morbidity and mortality, healthcare-associated infections (HAIs) are a significant public health concern. HAI surveillance plays a critical role in preventing and controlling these infections by providing accurate and timely data on the burden, trends, and risk factors associated with HAIs. In recent years, significant progress has been made in the development and implementation of HAI surveillance systems, both in high-income and low- and middle-income countries (LMICs). However, there are still many challenges that must be addressed, including resource limitations, lack of standardization, and data quality issues. This review provides a comprehensive overview of HAI surveillance, including its history, evolution, methods, tools, strengths, limitations, challenges, and opportunities. It highlights the importance of international collaboration and partnerships in strengthening HAI surveillance systems, as well as the need for continued research and improvement in this area. The findings of this review have important implications for policy and practice in HAI surveillance. They underscore the need for ongoing efforts to standardize and improve the quality of HAI surveillance data, as well as the importance of investing in emerging technologies and methods that can enhance the efficiency and accuracy of these systems. The review also highlights the critical role of international collaboration and partnerships in addressing the global burden of HAIs and provides recommendations for applying lessons learned from successful programs to other settings.

PDF Share
  1. Healthcare-associated infections (HAIS). Centers for Disease Control and Prevention. Published November 10, 2021. Accessed April 3, 2023.
  2. Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. New Engl J Med 2018;379(18):1732–1744. DOI: 10.1056/nejmoa1801550
  3. Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed 2017;7(5):478–482. DOI: 10.1016/j.apjtb.2017.01.019
  4. Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011;377(9761):228–241. DOI: 10.1016/s0140-6736(10)61458-4
  5. Report on the burden of endemic health care-associated infection worldwide. World Health Organization. 2011. Accessed April 3, 2023.
  6. Yokoe DS, Anderson DJ, Berenholtz SM, et al. Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates”. Infect Control Hosp Epidemiol 2014;35(5):455–459. DOI: 10.1086/675819
  7. Semmelweis I. Etiology, Concept and Prophylaxis of Childbed Fever. Madison: University of Wisconsin Press; 1983.
  8. Garner JS. Guideline for isolation precautions in hospitals. Infection Control & Hospital Epidemiology 1996;17(1):54–80. DOI: 10.1017/S0195941700006123
  9. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121(2):182–205. DOI: 10.1093/oxfordjournals.aje.a113990
  10. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470–485. DOI: 10.1016/S0196655304005425
  11. Centers for Disease Control and Prevention. NHSN overview. Available from:
  12. European Centre for Disease Prevention and Control. Healthcare-associated infections surveillance. Available from:
  13. van Mourik, Perencevich EN, Gastmeier P, et al. Designing surveillance of healthcare-associated infections in the era of automation and reporting mandates. Clin Infect Dis 2018;66(6):970–976. DOI: 10.1093/cid/cix835
  14. Jain R, Kralovic SM, Evans ME, et al. Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364(15):1419–1430. DOI: 10.1056/NEJMoa1007474
  15. Centers for Disease Control and Prevention. Electronic reporting for. public health. Available from:
  16. Allegranzi, B., Pittet, D., & Sax, H. (2016). WHO Guidelines for the prevention and control of antibiotic resistant infections in healthcare. Geneva: World Health Organization.
  17. Dantes R, Mu Y, Belflower R, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013;173(21):1970–1978. DOI: 10.1001/jamainternmed.2013.10423
  18. Centers for Disease Control and Prevention. National Healthcare Safety. Network (NHSN). Available from:
  19. Kanjilal S, Srinivasan A, Ghosh A. HAI surveillance systems: recent advances and challenges. J Hosp Infect 2017;97(2):142–148. DOI: 10.1016/j.jhin.2017.05.007
  20. Shenoy ES, Branch-Elliman W. Automating surveillance for healthcare-associated infections: rationale and current realities (Part I/III). Antimicrob Steward Healthc Epidemiol 2023;3(1): e25. DOI: 10.1017/ash.2022.312
  21. European Centre for Disease Prevention and Control. European surveillance of healthcare-associated infections in intensive care units: HAI-Net ICU protocol, version 2.2. Available from:
  22. Hauck K, Zhao X, Howie E, et al. Differences in surveillance methodologies: analysis of health care-associated infection (HAI) reporting in Shanghai and Hefei, China. Infect Control Hosp Epidemiol 2019;40(5):592–594.
  23. Marino M, Lucas J, Latour E, et al. Missing data in primary care research: importance, implications and approaches. Fam Pract 2021;38(2):200–203. DOI: 10.1093/fampra/cmaa134
  24. Wen R, Li X, Liu T, et al. Effect of a real-time automatic nosocomial infection surveillance system on hospital-acquired infection prevention and control. BMC Infect Dis 2022;22(1):857. DOI: 10.1186/s12879-022-07873-7
  25. Munier A, Biard L, Legrand P, et al. Epidemiology of healthcare-associated infections in a teaching hospital in Lyon, France: incidence, microbial diversity, and impact of surveillance. BMC Infect Dis 2019;19(1):760. DOI: 10.1186/s12879-019-4393-y
  26. World Health Organization. (2018). Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Retrieved from
  27. Goto M, Schweizer ML, Vaughan-Sarrazin M, et al. Data integrity of the national healthcare safety network (NHSN) in intensive care units (ICUs) in the United States. Infect Control Hosp Epidemiol 2018;39(9):1071–1077.
  28. European Centre for Disease Prevention and Control. (2012). Systematic review of surveillance systems for healthcare-associated infections in Europe.
  29. Storr J, Twyman A, Zingg W, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control 2017;6(1):6. DOI: 10.1186/s13756-016-0149-9
  30. Owens R, Macfarlane L, Bergin J, et al. A review of hospital-acquired infections in low- to middle-income countries and strategies for reducing it. Clin Microbiol Infect 2019;25(8):954–961.
  31. Coker D, Phuong HTK, Nguyen LTP, et al. Establishing a standardized surveillance system for health care-associated infections in Vietnam. Glob Health Sci Pract 2022;10(3):e2100284. DOI: 10.9745/GHSP-D-21-00284
  32. Cueva C, Winston D, Janssen L, et al. Data quality assessment of the healthcare-associated infection surveillance data in California hospitals. Open Forum Infectious Diseases 2015;2(suppl 1). DOI: 10.1093/ofid/ofv133.183
  33. Fitzpatrick F, Doherty A, Lacey G. Using artificial intelligence in infection prevention. Curr Treat Options Infect Dis 2020;12(2):135–144. DOI: 10.1007/s40506-020-00216-7
  34. Tamuzi JL, Gao J, Leung VC, et al. A scoping review of the application of artificial intelligence in infection control and prevention. Am J Infect Control 2020;48(12):1513–1518.
  35. Artificial intelligence and machine learning. Centers for Disease Control and Prevention July 3, 2023. Accessed October 10, 2023.
  36. Khoury MJ, Holt KE. The impact of genomics on precision public health: beyond the pandemic. Genome Med 2021;13(1):67. DOI: 10.1186/s13073-021-00886-y
  37. Electronic surveillance: slow adoption could hamper enhanced hai prevention efforts. Infection Control Today. Accessed October 10, 2023.
  38. EHR Intelligence. How to integrate a prescription drug monitoring program into the EHR. HER Intelligence. June 16, 2021. Accessed October 10, 2023. https://www.infection
  39. Diamond F. Integrate Hai tracking with ems. Infection Control Today. April 28, 2021. Accessed October 10, 2023.
  40. Li E, Clarke J, Neves AL, et al. Electronic health records, interoperability and patient safety in health systems of high-income countries: a systematic review protocol. BMJ Open. 2021;11(7):e044941. DOI: 10.1136/bmjopen-2020-044941
  41. Lowe H, Woodd S, Lange IL, et al. Challenges and opportunities for infection prevention and control in hospitals in conflict-affected settings: a qualitative study [published correction appears in Confl Health. 2022 Jan 7;16(1):2. Confl Health. 2021;15(1):94. DOI: 10.1186/s13031-021-00428-8
  42. World Health Organization. (2018). Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2016-2017.
  43. Centers for Disease Control and Prevention. (2020). Global health security: partnerships and initiatives.
  44. European Centre for Disease Prevention and Control. (2020). Surveillance of healthcare-associated infections and prevention indicators in European intensive care units: HAI-Net ICU protocol, version 3.3. Stockholm: ECDC.
  45. Martin E, Rao G. Research priorities in healthcare epidemiology and infection prevention: results of a survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol 2018;39(4):440–445.
  46. Limmathurotsakul D, Peacock SJ, Limmathurotsakul S. Challenges and obstacles for estimation of the true burden of melioidosis. Emerg Infect Dis 2016;22(2):e141581.
  47. Morrison-Smith S, Ruiz J. Challenges and barriers in virtual teams: a literature review. SN Appl Sci 2020;2:1096. DOI: 10.1007/s42452-020-2801-5
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.